Athanassios Argiris
Division of Hematology-Oncology
Department of Medicine
University of Pittsburgh School of Medicine
Pittsburgh
Pennsylvania
Name/email consistency: high
- A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the eastern cooperative oncology group (E1303). Argiris, A., Ghebremichael, M., Burtness, B., Axelrod, R.S., Deconti, R.C., Forastiere, A.A. Cancer (2011)
- Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. Argiris, A., Karamouzis, M.V., Gooding, W.E., Branstetter, B.F., Zhong, S., Raez, L.E., Savvides, P., Romkes, M. J. Clin. Oncol. (2011)
- Empowering induction therapy for locally advanced head and neck cancer. Argiris, A., Karamouzis, M.V. Ann. Oncol. (2011)
- Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. Argiris, A., Heron, D.E., Smith, R.P., Kim, S., Gibson, M.K., Lai, S.Y., Branstetter, B.F., Posluszny, D.M., Wang, L., Seethala, R.R., Dacic, S., Gooding, W., Grandis, J.R., Johnson, J.T., Ferris, R.L. J. Clin. Oncol. (2010)
- Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Argiris, A., Buchanan, A., Brockstein, B., Kolesar, J., Ghebremichael, M., Pins, M., Hahn, K., Axelrod, R., Forastiere, A. Cancer (2009)
- Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer. Argiris, A., Karamouzis, M.V., Johnson, J.T., Heron, D.E., Myers, E., Eibling, D., Cano, E., Urba, S., Gluckman, J., Grandis, J.R., Wang, Y., Agarwala, S.S. Laryngoscope (2008)
- A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer. Argiris, A., Agarwala, S.S., Karamouzis, M.V., Burmeister, L.A., Carty, S.E. Invest. New. Drugs (2008)
- Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story. Argiris, A., Hensing, T., Yeldandi, A., Patel, S., Raji, A., Sturgis, C., Masters, G., Gooding, W., Pins, M., Kolesar, J. J. Thorac. Oncol (2006)
- A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Argiris, A., Cohen, E., Karrison, T., Esparaz, B., Mauer, A., Ansari, R., Wong, S., Lu, Y., Pins, M., Dancey, J., Vokes, E. Cancer Biol. Ther. (2006)
- Induction chemotherapy for head and neck cancer: will history repeat itself?. Argiris, A. J. Natl. Compr. Canc. Netw (2005)









